leadf
logo-loader
viewInnovus Pharmaceuticals, Inc.

Innovus Pharma buys Beyond Human assets for US$630

Beyond Human’s most well-known products include a natural testosterone booster supplement and natural Human Growth Agent HGA.

shutterstock_144658310.jpg
Innovus Pharmaceuticals is an over the counter respiratory health product specialist

Over the counter respiratory health product specialist Innovus Pharmaceuticals, (OTC:INNV), has agreed to buy all assets from Texas-based Beyond Human LLC for US$630,000.

Innovus said, following the new all-cash deal, it expects its annual revenue to triple to close to US$4.0mln and will help it become cash flow positive in the near future.

Dr Bassam Damaj, chief executive of Innovus Pharma, said the deal was a “transformative acquisition,” adding that “with this acquisition, we will have a total of 14 products now in the fields of men and women health and we believe that Innovus Pharma will become a strong player in this category.”

Beyond Human’s most well-known products include the natural testosterone booster supplement Beyond T Human and its natural Human Growth Agent HGA.

Its sales, which are concentrated in the US, have been growing at almost 50% per year for the last two years, and in 2015, the firm had over US$2.2mln in gross revenues and net profit of US$400,000.

According to market experts, the US testosterone replacement market grew from US$1.6bn in 2011 to US$2.4bn in 2013 and is expected to hit US$3.8 billion in 2018.

Quick facts: Innovus Pharmaceuticals, Inc.

Price: - -

OTCMKTS:INNV
Market: OTCQB
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Ascendant Resources drill program continues looking to expand south zone at...

Ascendant Resources (TSE: AND) President and CEO Chris Buncic joined Steve Darling from Proactive with news the company's drill program continues as the look at the South Zone of the Lagoa Salgada Project in Portugal. Buncic telling Proactive they are expecting to have results from this...

15 hours, 30 minutes ago

2 min read